Nobilis Health Announces New In-Network Contract at Plano Surgical Hospital
HOUSTON, Aug. 28, 2018
HOUSTON, Aug. 28, 2018 /PRNewswire/ -- Nobilis Health Corp. (NYSE American: HLTH) (NEO: HLTH) ("Nobilis" or the "Company") announced today that it has entered into an in-network contract ("Payor Agreement") at Plano Surgical Hospital with one of the nation's largest commercial payors. The Payor Agreement is effective October 15, 2018.
"We anticipate the implementation of this contract to significantly improve Nobilis' system-wide contract revenue mix, with the Texas market alone expected to increase its in-network revenue exposure to approximately 55% of annual facility revenues. The execution of this agreement represents a major step in Nobilis Health's development as a comprehensive health system with a focus on in-network facilities. This contract will further augment the progress we have seen in the past couple of months following the introduction of a key new hire and leader in our revenue cycle department," said Harry Fleming, CEO.
"I am extremely pleased at the progress our revenue cycle management team has achieved since I joined Nobilis two months ago," said Melinda Taylor, Nobilis' Senior Vice President of Revenue Cycle Management. "Intensive scrutiny of existing billing processes alongside selective re-education of revenue cycle management personnel on best practices has already led to a 7 day reduction of our DSO period. With the implementation of this in-network contract at Plano Surgical Hospital, we expect to see additional, significant improvement in the DSO figure by the end of the year. We will build on the momentum created these past couple of months as we continue to identify new opportunities to refine and optimize Nobilis' revenue collection operations."
About Nobilis Health Corp.
Nobilis Health (www.NobilisHealth.com) is a full-service healthcare development and management company, with more than 30 locations across Texas and Arizona, including hospitals, ambulatory surgery centers, and multi-specialty clinics. In addition, Nobilis Health partners with more than 30 facilities across the country. Marketing nine independent brands, Nobilis Health deploys a unique patient acquisition strategy driven by proprietary, direct-to-consumer marketing technology, focusing on a specified set of procedures that are performed at its facilities by local physicians. Nobilis Health's business model connects patients with physicians and delivers the highest quality healthcare.
This press release contains certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner.
We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to a mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed on March 12, 2018, as updated by other filings with the Securities and Exchange Commission.
Vice President, Corporate Development
View original content with multimedia:http://www.prnewswire.com/news-releases/nobilis-health-announces-new-in-network-contract-at-plano-surgical-hospital-300703048.html
SOURCE Nobilis Health Corp.